首页> 外文学位 >Monochromatic x-ray cancer phototherapy and characterization of the Compton Light Source.
【24h】

Monochromatic x-ray cancer phototherapy and characterization of the Compton Light Source.

机译:单色X射线癌症光疗和康普顿光源的表征。

获取原文
获取原文并翻译 | 示例

摘要

The Compton Light Source (CLS) promises to provide a compact source of high intensity, well-collimated, small spot size, hard x-rays with tunable monochromatic energy. By colliding relativistic electrons with picosecond photon bunches, x-rays are generated through inverse Compton scattering (ICS). The tunable energy range of these x-ray photons (10-120 keV) is well suited for diverse medical applications allowing work, which is now possible only at synchrotron sources, to take place in a clinical or local research setting. High quality images and better tumor control with lower dose on normal tissue may be achieved with x-rays tuned just above the k-edge characteristic energies of the contrast agents. This dissertation first considers design, initial beam alignment and x-ray detection efforts at the CLS. In particular, methods to characterize the system performance and to detect x-rays generated by inverse Compton scattering are discussed. Although a significant background bremsstrahlung field was produced during ICS x-ray generation, a small signal (∼9.1% above noise) of ICS x-rays was measured against the background during initial alignment efforts.;The dissertation then considers the in vitro evaluation of PC3 prostate cancer cells treated with radiosensitizing agents such as lohexol and tin protoporphyrin IX (SnPPIX) to demonstrate the dose enhancement effect under irradiation by both conventional and synchrotron x-ray sources. A dose enhancement factor at 10% cell survival (DEF10%) of 1.66 was measured for cells treated with lohexol at 14 mg/ml using a hardened conventional x-ray source. Synchrotron experiments at the Stanford Synchrotron Radiation Laboratory confirmed the predicted energy dependence of the dose enhancement factor for cells in solution with 28 mg/ml lohexol. The relationship between DEF10% and energy was experimentally determined for energies between 25 and 42 keV. Although irradiation below the k-edge of iodine showed only small dose enhancement (DEF10% of 1.16, 1.2 and 1.37 at 25, 28, and 32 keV, respectively), irradiation above the k-edge increased dose enhancement (DEF10% of 1.7, 2.12, and 2.24 at 33.4, 34, and 42 keV, respectively). Experiments with extracellular SnPPIX at a conventional x-rays source showed modest dose enhancement (DEF10%=1.17), but the inherent toxicity of SnPPIX precluded evaluation at distant synchrotron sources.
机译:康普顿光源(CLS)有望提供一种紧凑的高强度,准直,小光斑尺寸,具有可调单色能量的硬X射线源。通过使相对论电子与皮秒光子束碰撞,通过逆康普顿散射(ICS)产生X射线。这些X射线光子的可调节能量范围(10-120 keV)非常适合于各种医疗应用,从而允许在临床或本地研究环境中进行工作,而现在仅在同步加速器源中才可以进行工作。通过将X射线调整到刚好超过造影剂的k边缘特征能量,可以在正常组织上以较低的剂量获得高质量的图像和更好的肿瘤控制。本文首先考虑了CLS的设计,初始光束对准和X射线检测工作。特别地,讨论了表征系统性能和检测由逆康普顿散射产生的X射线的方法。尽管在ICS X射线产生过程中产生了显着的背景致辐射场,但在初始对准工作期间,在背景下测得了一个小的ICS X射线信号(比噪声高约9.1%)。用放射增敏剂(如lohexol和锡原卟啉IX(SnPPIX))处理的PC3前列腺癌细胞在常规和同步加速器X射线源照射下均表现出剂量增强作用。使用硬化的常规X射线源,以14 mg / ml的洛美索处理的细胞在10%细胞存活率下的剂量增强因子(DEF10%)为1.66。斯坦福同步加速器辐射实验室的同步加速器实验证实了剂量为28 mg / ml的六氢己酚溶液中细胞的剂量增强因子的预期能量依赖性。对于25至42 keV之间的能量,实验确定了DEF10%与能量之间的关系。尽管在碘的k边缘以下进行辐照仅显示少量剂量增加(在25、28和32 keV时分别为1.16、1.2和1.37的DEF10%),但在k边缘以上的辐照却增加剂量增加(DEF10%为1.7,分别在33.4、34和42 keV时分别为2.12和2.24)。在常规X射线源上进行细胞外SnPPIX的实验显示适度的剂量增加(DEF10%= 1.17),但是SnPPIX的固有毒性无法在遥远的同步加速器源进行评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号